The AABB is inviting nominations for its 2026-27 Board of Directors, with applications due by March 4. Candidates must submit a letter of intent, CV, and address key priorities and diversity contributions.
The Association for the Advancement of Blood & Biotherapies (AABB) has published a call for nominations for their 2026-27 AABB Board of Directors. Applications are due March 4, according to an announcement.
Open positions include officers and at-large directors. AABB is asking applicants to submit a letter of intent detailing “their willingness to serve, along with a brief description of their qualifications and a current CV.” They are also required to tell the Nominating Committee what they view “as the two most critical priorities for AABB during the next year” and their part in executing the priorities as a member of the board. Additionally, applicants should include an explanation of how they “would enrich the diversity of the board.”
